ESC Congress 22 — Dr Harriette Van Spall (McMaster University, CA) sits down with PI, Dr Scott D Solomon (Brigham & Women's Hospital & Harvard Medical School, US) to discuss one of the most awaited trials of 2022, DELIVER (NCT03619213). 

This study assessed the effect of dapagliflozin 10 mg versus placebo, given once daily in addition to background regional standard of care therapy, including treatments to control co-morbidities, in reducing the composite of CV death or heart failure events.

Editor: Mirjam Boros

Videographer: Oliver Miles